Clinical trial
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant…
NCT00039858 · Encysive Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00039858 |
|---|---|
| Title | Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin |
| Official title | Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin |
| Lead sponsor | Encysive Pharmaceuticals, Industry |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Thrombocytopenia, Thrombosis |
| Intervention type | Drug |
| Interventions | Argatroban |
| Enrollment | 24 |
| Start date | Sep 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Jun 14, 2002 |
| Last update posted | Jan 11, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: